AZN Astrazeneca Plc

11,268.00

18.00 (0.16%)

23 Apr 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Astrazeneca Plc	LSE:AZN	London	Ordinary Share	GB0009895292	ORD SHS $0.25

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	18.00	0.16%	11,268.00	11,222.00	11,226.00	11,362.00	11,220.00	11,250.00	3,556,178	16:35:27

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Pharmaceutical Preparations	45.81B	5.96B	3.8415	29.21	173.96B

AstraZeneca: European Agency Accepts Variation to Application for Tagrisso

28/11/2017 7:45am

Dow Jones News

Astrazeneca (LSE:AZN)
Historical Stock Chart

From Apr 2019 to Apr 2024

   By Adria Calatayud

AstraZeneca PLC (AZN.LN) said Tuesday that the European Medicines Agency has accepted a variation to its marketing-authorization application for Tagrisso, for treatment of adult patients with locally-advanced or metastatic non-small cell lung cancer.

The pharmaceutical company said the drug application, which is an epidermal growth factor receptor inhibitor, was based on data from the phase 3 trial, in which Tagrisso significantly improved progression-free survival compared to current treatments.

On Monday, AstraZeneca reported the submission of a supplemental new drug application to Japan's Pharmaceuticals and Medical Devices Agency for the use of Tagrisso.

Write to Adria Calatayud at adria.calatayudvaello@dowjones.com

(END) Dow Jones Newswires

November 28, 2017 02:30 ET (07:30 GMT)